Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 24 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07130071Not Yet Recruiting

Channelling Algorithm Proficiency To Understand, Recognise and Elucidate Disease

Role: lead

NCT02294279Phase 4Completed

The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms

Role: lead

NCT02388373Phase 4Completed

A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down

Role: lead

NCT02570425Not ApplicableCompleted

Comparing Maintenance of Device Mastery With Turbohaler© vs. Spiromax© in Healthcare Professionals naïve to Both Devices

Role: lead

NCT01794390Completed

Handling Inhalers - Technique Error Comparison (HI-TEC)

Role: lead

NCT02195739Unknown

Nicotine Replacement Therapy and Cardiovascular Disease

Role: lead

NCT02140684Suspended

Exhaled Nitric Oxide in Asthma Management

Role: lead

NCT02140541Unknown

The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils

Role: lead

NCT02140671Unknown

Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes

Role: lead

NCT01786720Unknown

Analysis of the Time Taken to Triple Therapy (NOVARTIS)

Role: lead

NCT02048930Completed

Real Life Effectiveness of Easyhaler (Orion)

Role: lead

NCT01287351Completed

Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study

Role: lead

NCT01908075Completed

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management

Role: lead

NCT01877954Completed

Qvar vs FP in Pediatrics

Role: lead

NCT01875276Completed

Evaluating the Need for New Rhinitis Treatment

Role: lead

NCT01141439Completed

Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management

Role: lead

NCT01729351Completed

Qvar Therapy in Smoking Asthmatics

Role: lead

NCT01400217Completed

Qvar Versus Clenil, a General Practice Research Database Study

Role: lead

NCT01697722Completed

Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy

Role: lead

NCT01655667Completed

Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis

Role: lead